SMITHKLINE REQUIP FOR PARKINSON's WILL BE AVAILABLE WITHIN A FEW WEEKS OF SEPT. 19 APPROVAL; ROPINIROLE-ASSOCIATED SYNCOPE INCLUDED IN LABELED WARNINGS
Executive Summary
SmithKline Beecham's Parkinson's disease therapy Requip will be available within a few weeks of its Sept. 19 approval, the company said.